Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Rifaximin 200 mg
DRUG
2 trials
Sponsors
Zagazig University
, Sun Yat-sen University
Conditions
Effect of Drug
HBV
Hepatic Encephalopathy
Hepatitis B
Liver Failure, Acute on Chronic
Rifaximin
Type2 Diabetes
Early Phase 1
The Efficacy and Safety of Rifaximin Treatment
NCT05786859
Sun Yat-sen University
Effect of Drug, HBV, Hepatic Encephalopathy +3
Start: 2023-03-09
End: 2025-10-31
Target: 124
Updated: 2023-03-28
Unknown Phase
Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes
NCT03758144
Zagazig University
Type2 Diabetes
Start: 2018-11-01
End: 2019-07-01
Target: 80
Updated: 2018-11-29